Analyze Diet
Scientific reports2025; 15(1); 14633; doi: 10.1038/s41598-025-93661-7

Astaxanthin supplementation in Arabian racing horses mitigates oxidative stress and inflammation in peripheral blood mononuclear cells through enhanced mitophagy.

Abstract: Astaxanthin, a strong antioxidant carotenoid, has shown promising features in mitigating inflammation and oxidative stress and so that has been considered as a supplement for high-performance animals. In this study, we aimed to evaluate the effects of astaxanthin on oxidative stress, inflammation, and mitochondrial health in peripheral blood mononuclear cells (PBMC) isolated from Arabian racehorses. Horse-derived peripheral blood mononuclear cells exposed to hydrogen peroxide (H₂O₂) presented increased reactive oxygen species (ROS) accumulation and overexpression of pro-inflammatory cytokines such as IL-1β, IL-6, IFN-γ, and TNF-α. The addition of astaxanthin to cell culture reduced H₂O₂-induced inflammatory response by decreasing the expression levels of all the tested pro-inflammatory cytokines. Moreover, astaxanthin displayed a potential antioxidant response by increasing the expression of genes related to antioxidative defense, such as NRF1, SOD2, and GPX. Interestingly, PBMCs isolated from the horses orally supplemented with astaxanthin increased the expression of the mitophagy-related genes PINK1 and PARKIN. Moreover, genes related to mitochondrial dynamics and energy production, such as PPARGC1B, NDUFA9, and MRPL24, as well as genes associated with mitochondrial function, structure and dynamics, such as PIGBOS, MRLP24, PUSL1 and TFAM were upregulated in PBMCs isolated from astaxanthin supplemented horses. Altogether, these findings indicate that astaxanthin may be a beneficial dietary supplement for equine health, supporting resilience against oxidative stress and inflammatory challenges, and improving the recovery and performance of racing horses.
Publication Date: 2025-04-26 PubMed ID: 40287452PubMed Central: PMC12033344DOI: 10.1038/s41598-025-93661-7Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores the benefits of antioxidant astaxanthin supplementation in Arabian racehorses. It demonstrates that astaxanthin helps reduce inflammation and oxidative stress, and it improves mitochondrial health in horses’ blood cells.

Objective of the Research

  • The primary objective of this study was to investigate the effects of astaxanthin supplementation in Arabian racehorses. Specifically, the researchers focused on the mitigating effects on oxidative stress and inflammation, as well as its impact on the health of mitochondria in peripheral blood mononuclear cells (PBMC) taken from the horses.

Methodology

  • The researchers used horse-derived PBMCs exposed to hydrogen peroxide (H₂O₂), a condition causing an increase in the accumulation of reactive oxygen species (ROS), a group of chemically reactive molecules containing oxygen known to cause damage through oxidative stress. This exposure also led to an overexpression of pro-inflammatory cytokines, such as IL-1β, IL-6, IFN-γ, and TNF-α.
  • Astaxanthin was added to the cell culture to observe its effect on the H₂O₂-induced inflammatory response. The researchers focused on measuring changes in the expression levels of the examined pro-inflammatory cytokines.

Results

  • The study found that astaxanthin lessened the H₂O₂-induced inflammatory response by reducing the expression levels of all the studied pro-inflammatory cytokines.
  • In demonstrating an antioxidant response, astaxanthin increased the expression of genes tied to antioxidant defense, including NRF1, SOD2, and GPX.

Additional Findings

  • Further, the research presented an interesting outcome where PBMCs from horses that had orally taken astaxanthin showed boosted expression of mitophagy-related genes PINK1 and PARKIN. The same cells also showed an upregulation of genes associated with mitochondrial dynamics and energy production, like PPARGC1B, NDUFA9, and MRPL24, along with genes associated with mitochondrial functionality, structure, and dynamics, including PIGBOS, MRLP24, PUSL1 and TFAM.
  • In conclusion, these findings suggest the potential utility of astaxanthin as a useful dietary supplement for equine health, aiding resilience against oxidative stress and inflammatory challenges and aiding the recovery and performance of racing horses.

Cite This Article

APA
Giercuszkiewicz-Hecold B, Pajuelo D, Steczkiewicz Z, Cywinska A, Marycz K. (2025). Astaxanthin supplementation in Arabian racing horses mitigates oxidative stress and inflammation in peripheral blood mononuclear cells through enhanced mitophagy. Sci Rep, 15(1), 14633. https://doi.org/10.1038/s41598-025-93661-7

Publication

ISSN: 2045-2322
NlmUniqueID: 101563288
Country: England
Language: English
Volume: 15
Issue: 1
Pages: 14633
PII: 14633

Researcher Affiliations

Giercuszkiewicz-Hecold, Beata
  • Doctoral School, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159c, 02-776, Warsaw, Poland.
Pajuelo, David
  • Faculty of Health Sciences, Universidad Europea de Valencia, 46010, Valencia, Spain.
Steczkiewicz, Zofia
  • Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life Sciences, Norwida 27B, 50-375, Wrocław, Poland.
Cywinska, Anna
  • Department of Basic and Preclinical Sciences, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University in Torun, Lwowska 1, 87-100, Toruń, Poland.
Marycz, Krzysztof
  • International Institute of Translational Medicine (MIMT), ul. Jesionowa 11, 55-114, Malin Wisznia Mała, Poland. kmmarycz@ucdavis.edu.

MeSH Terms

  • Animals
  • Horses
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • Oxidative Stress / drug effects
  • Xanthophylls / pharmacology
  • Xanthophylls / administration & dosage
  • Dietary Supplements
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Mitophagy / drug effects
  • Cytokines / metabolism
  • Antioxidants / pharmacology
  • Reactive Oxygen Species / metabolism
  • Hydrogen Peroxide / pharmacology
  • Mitochondria / drug effects
  • Mitochondria / metabolism

Conflict of Interest Statement

Declarations. Ethics approval and consent to participate: All the procedures of blood sampling were performed as part of routine health examination, therefore, according to the European directive EU/2010/63 and Polish regulations regarding experiments on animals, there was no need for the approval of the Ethics Committee for the described procedures. Nevertheless, the experimental protocols were described and submitted to the 2nd Local Ethical Committee for Animal Experiments at the Warsaw University of Life Sciences (SGGW). The protocols were qualified as “no need for approval” by this committee, since they were considered as non-experimental clinical veterinary procedures. A written consent for the use of blood for scientific analyses was obtained from the trainer. Competing interests: The authors declare no competing interests.

References

This article includes 44 references
  1. Bjørklund G. The role of astaxanthin as a nutraceutical in health and age-related conditions.. Mol. Basel Switz. 27, 7167 (2022).
    pmc: PMC9655540pubmed: 36363994
  2. Higuera-Ciapara I, Félix-Valenzuela L, Goycoolea FM. Astaxanthin: A review of its chemistry and applications.. Crit. Rev. Food Sci. Nutr. 46, 185–196 (2006).
    pubmed: 16431409
  3. Giercuszkiewicz-Hecold B. Astaxanthin supplementation does not alter training-related changes in inflammatory cytokine profile in Arabian racing horses.. Antioxidants 13, 905 (2024).
    pmc: PMC11351528pubmed: 39199150
  4. Mularczyk M, Bourebaba N, Marycz K, Bourebaba L. Astaxanthin carotenoid modulates oxidative stress in adipose-derived stromal cells isolated from equine metabolic syndrome affected horses by targeting mitochondrial biogenesis.. Biomolecules 12, 1039 (2022).
    pmc: PMC9405637pubmed: 36008933
  5. Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications–a review.. Mar. Drugs. 12, 128–152 (2014).
    pmc: PMC3917265pubmed: 24402174
  6. Giercuszkiewicz-Hecold B. The effect of long term Astaxanthin supplementation on the antioxidant status of racing Arabian horses – preliminary study.. Sci. Rep. 14, 27991 (2024).
    pmc: PMC11564757pubmed: 39543175
  7. Chew BP. Dietary Astaxanthin enhances immune response in dogs.. Vet. Immunol. Immunopathol. 140, 199–206 (2011).
    pubmed: 21208664
  8. Murai T. Effects of Astaxanthin supplementation in healthy and obese dogs.. Vet. Med. Auckl. NZ. 10, 29–35 (2019).
    pmc: PMC6385744pubmed: 30859086
  9. Shono S, Gin A, Minowa F, Okubo K, Mochizuki M. The oxidative stress markers of Horses-the comparison with other animals and the influence of exercise and disease.. Anim. Open. Access. J. MDPI. 10, 617 (2020).
    pmc: PMC7222798pubmed: 32260122
  10. Gambini J, Stromsnes K. Oxidative stress and inflammation: from mechanisms to therapeutic approaches.. Biomedicines 10, 753 (2022).
    pmc: PMC9031318pubmed: 35453503
  11. Bundgaard L, Sørensen M, Aa. Nilsson T, Salling E, Jacobsen S. Evaluation of systemic and local inflammatory parameters and manifestations of pain in an equine experimental wound model.. J. Equine Vet. Sci. 68, 81–87 (2018).
    pubmed: 31256894
  12. Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K. Molecular mechanisms and physiological functions of mitophagy.. EMBO J. 40, e104705 (2021).
    pmc: PMC7849173pubmed: 33438778
  13. Kong L. Mitophagy in relation to chronic inflammation/ROS in aging.. Mol. Cell. Biochem. .
    pubmed: 38834837doi: 10.1007/s11010-024-05042-9google scholar: lookup
  14. Wang Y, Liu N, Lu B. Mechanisms and roles of mitophagy in neurodegenerative diseases.. CNS Neurosci. Ther. 25, 859–875 (2019).
    pmc: PMC6566062pubmed: 31050206
  15. Siasos G. Mitochondria and cardiovascular diseases-from pathophysiology to treatment.. Ann. Transl Med. 6, 256 (2018).
    pmc: PMC6046286pubmed: 30069458
  16. Matsuda S, Kitagishi Y, Kobayashi M. Function and characteristics of PINK1 in mitochondria.. Oxid. Med. Cell. Longev. 2013, 601587 (2013).
    pmc: PMC3600171pubmed: 23533695
  17. Ge P, Dawson VL, Dawson TM. PINK1 and parkin mitochondrial quality control: a source of regional vulnerability in parkinson’s disease.. Mol. Neurodegener. 15, 20 (2020).
    pmc: PMC7071653pubmed: 32169097
  18. Yu R. MIEF1/2 orchestrate mitochondrial dynamics through direct engagement with both the fission and fusion machineries.. BMC Biol. 19, 229 (2021).
    pmc: PMC8532385pubmed: 34674699
  19. Xian H, Liou YC. Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy.. Autophagy 15, 2107–2125 (2019).
    pmc: PMC6844504pubmed: 30894073
  20. Chu Q. Regulation of the ER stress response by a mitochondrial microprotein.. Nat. Commun. 10, 4883 (2019).
    pmc: PMC6814811pubmed: 31653868
  21. Chen B. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.. BMC Med. Genomics. 15, 274 (2022).
    pmc: PMC9805199pubmed: 36587194
  22. Rius-Pérez S, Torres-Cuevas I, Millán I, Ortega ÁL, Pérez SP. PGC-1α, inflammation, and oxidative stress: an integrative view in metabolism.. Oxid. Med. Cell. Longev. 2020, 1452696 (2020).
    pmc: PMC7085407pubmed: 32215168
  23. Emahazion T, Beskow A, Gyllensten U, Brookes AJ. Intron based radiation hybrid mapping of 15 complex I genes of the human electron transport chain.. Cytogenet. Cell. Genet. 82, 115–119 (1998).
    pubmed: 9763677
  24. Baertling F. NDUFA9 point mutations cause a variable mitochondrial complex I assembly defect.. Clin. Genet. 93, 111–118 (2018).
    pubmed: 28671271
  25. Di Nottia M. A homozygous MRPL24 mutation causes a complex movement disorder and affects the mitoribosome assembly.. Neurobiol. Dis. 141, 104880 (2020).
    pubmed: 32344152
  26. Busch JD. MitoRibo-Tag mice provide a tool for in vivo studies of mitoribosome composition.. Cell. Rep. 29, 1728–1738e9 (2019).
    pmc: PMC6859486pubmed: 31693908
  27. Ngo HB, Lovely GA, Phillips R, Chan DC. Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation.. Nat. Commun. 5, 3077 (2014).
    pmc: PMC3936014pubmed: 24435062
  28. Homberg B, Rehling P, Cruz-Zaragoza LD. The multifaceted mitochondrial OXA insertase.. Trends Cell. Biol. 33, 765–772 (2023).
    pubmed: 36863885
  29. Thompson K. OXA1L mutations cause mitochondrial encephalopathy and a combined oxidative phosphorylation defect.. EMBO Mol. Med. 10, e9060 (2018).
    pmc: PMC6220311pubmed: 30201738
  30. Goto S. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid Astaxanthin.. Biochim. Biophys. Acta. 1512, 251–258 (2001).
    pubmed: 11406102
  31. Peng JJ. A circuit-dependent ROS feedback loop mediates glutamate excitotoxicity to sculpt the Drosophila motor system.. eLife 8, e47372 (2019).
    pmc: PMC6682402pubmed: 31318331
  32. Ni Y. Protective effects of Astaxanthin on a combination of D-galactose and jet lag-induced aging model in mice.. Endocr. J. 65, 569–578 (2018).
    pubmed: 29526991
  33. Kim SH, Kim H. Inhibitory effect of Astaxanthin on oxidative stress-induced mitochondrial dysfunction-a mini-review.. Nutrients 10, 1137 (2018).
    pmc: PMC6165470pubmed: 30134611
  34. Park JS, Chyun JH, Kim YK, Line LL, Chew BP. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans.. Nutr. Metab. 7, 18 (2010).
    pmc: PMC2845588pubmed: 20205737
  35. Wang Z. Identifying mitophagy-related genes as prognostic biomarkers and therapeutic targets of gastric carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data.. Comput. Biol. Med. 163, 107227 (2023).
    pubmed: 37413850
  36. Tian J, Zhang L, Shi K, Yang L. The role of mitophagy-related genes in prognosis and immunotherapy of cutaneous melanoma: a comprehensive analysis based on single-cell RNA sequencing and machine learning.. Immunol. Res. 73, 30 (2025).
    pubmed: 39799269
  37. Nishida Y, Nawaz A, Hecht K, Tobe K. Astaxanthin as a novel mitochondrial regulator: A new aspect of carotenoids, beyond antioxidants.. Nutrients 14, 107 (2021).
    pmc: PMC8746862pubmed: 35010981
  38. Liu R. Impaired mitochondrial dynamics and bioenergetics in diabetic skeletal muscle.. PloS One. 9, e92810 (2014).
    pmc: PMC3962456pubmed: 24658162
  39. Dujíčková L. Astaxanthin added during post-warm recovery mitigated oxidative stress in bovine vitrified oocytes and improved quality of resulting blastocysts.. Antioxid. Basel Switz. 13, 556 (2024).
    pmc: PMC11117980pubmed: 38790660
  40. Bourebaba L. The PTP1B inhibitor MSI-1436 ameliorates liver insulin sensitivity by modulating autophagy, ER stress and systemic inflammation in equine metabolic syndrome affected horses.. Front. Endocrinol. 14, 1149610 (2023).
    pmc: PMC10067883pubmed: 37020593
  41. Chiu HY, Tsao LY, Yang RC. Heat-shock response protects peripheral blood mononuclear cells (PBMCs) from hydrogen peroxide-induced mitochondrial disturbance.. Cell. Stress Chaperones. 14, 207–217 (2009).
    pmc: PMC2727987pubmed: 18763057
  42. Bourebaba L, Michalak I, Baouche M, Kucharczyk K, Marycz K. Cladophora glomerata methanolic extract promotes chondrogenic gene expression and cartilage phenotype differentiation in equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome.. Stem Cell. Res. Ther. 10, 392 (2019).
    pmc: PMC6916455pubmed: 31847882
  43. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.. Anal. Biochem. 162, 156–159 (1987).
    pubmed: 2440339
  44. Bourebaba N, Sikora M, Qasem B, Bourebaba L, Marycz K. Sex hormone-binding Globulin (SHBG) mitigates ER stress and improves viability and insulin sensitivity in adipose-derived mesenchymal stem cells (ASC) of equine metabolic syndrome (EMS)-affected horses.. Cell. Commun. Signal. CCS. 21, 230 (2023).
    pmc: PMC10496240pubmed: 37697311

Citations

This article has been cited 0 times.